<?xml version="1.0" encoding="UTF-8"?>
<p>The samples included sequences collected both from treatment-experienced (n = 176, 18.21%) and antiretroviral-naive (n = 790, 81.87%) patients diagnosed in Poland from 1989 to 2014, prior to the introduction of the antiretroviral treatment. Data for subtype B treatment-naive patients were partially collected as a part of the Northern-Poland Resistance Transmission Tracking for HIV-1 (NoRTTH) project funded by the Polish AIDS Society, and the resistance data were previously published elsewhere [
 <xref rid="pone.0172473.ref013" ref-type="bibr">13</xref>]. For the molecular clock analyses sequence sampling dates were used. For individuals with multiple sequences available, the earliest sequence after the positive confirmation HIV test, was included.
</p>
